Found 179 matching trials
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity PHASE2 This research study is studying the combination of anakinra and axicabtagen...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer PHASE1 PD1-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer...
Location
The First Affiliated Hospital, Zhejiang University
Learn More & Join Trial
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies EARLY_PHASE1 Current treatments for relapsed/refractory hematopoietic malignancies such ...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL PHASE1 The purpose of this study is to evaluate the safety and efficiency of autol...
Show More Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Learn More & Join Trial
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors PHASE1 The proposed clinical study is a Phase 1/2a trial to investigate the safety...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma PHASE1 This is a Phase 1, multicenter, open-label study o evaluate the safety and ...
Show More Location
Hematology Department of the First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma PHASE2 This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma PHASE1 This phase I trial tests the safety and side effects of B-cell activating f...
Show More Location
City of Hope Medical Center
Learn More & Join Trial